Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Breast cancer drug approvals by the US FDA from 1949 to 2018

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 19, 11 (2020)



The authors thank A. Mollet at the European Center for Pharmaceutical Medicine, University of Basel, Switzerland, for her support.

Updates & Corrections

  • Correction 14 January 2020: The author affiliations in the pdf were incorrect. These have now been corrected in the online pdf.

Supplementary Information

  1. Supplementary Box 1
  2. Supplementary Tables

Competing Interests

C.P.L. is employed by HBM Partners, which invests in emerging biotech companies.

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links